blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1299421

EP1299421 - ANTIBODIES TO HUMAN MCP-1 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.01.2010
Database last updated on 12.07.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY		published on 09.11.2011  [2011/45]
Applicant(s)For:BE  CH  CY  DE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
[N/P]
Former [2009/13]For:BE  CH  CY  DE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
NOVARTIS AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2003/47]For:BE  CH  CY  DE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2003/15]For:BE  CH  CY  DE  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
Novartis AG
Klybeckstrasse 141
4002 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Inventor(s)01 / HIESTAND, Peter
Schönenbuchstrasse 13A
CH-4123 Allschwil / CH
02 / HOFSTETTER, Hans
Chrischonaweg 92
CH-4125 Riehen / CH
03 / PAYNE, Trevor, Glyn
Dalmazirain 26
CH-3005 Berne / CH
04 / URFER, Roman
Vogesenstrasse 73
CH-4056 Basel / CH
05 / DI PADOVA, Franco, E.
Kluenenfeldstrasse 45
CH-4127 Birsfelden / CH
 [2003/15]
Representative(s)Gros, Florent, et al
Novartis AG
Corporate Intellectual Property
Patent & Trademark Department CH
4002 Basel / CH
[N/P]
Former [2003/15]Gros, Florent, et al
Novartis AG Corporate Intellectual Property, Patent & Trademark Department CH
4002 Basel / CH
Application number, filing date01962800.729.06.2001
[2003/15]
WO2001EP07468
Priority number, dateGB2000001613830.06.2000         Original published format: GB 0016138
[2003/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0202640
Date:10.01.2002
Language:EN
[2002/02]
Type: A2 Application without search report 
No.:EP1299421
Date:09.04.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2002 takes the place of the publication of the European patent application.
[2003/15]
Type: B1 Patent specification 
No.:EP1299421
Date:25.03.2009
Language:EN
[2009/13]
Search report(s)International search report - published on:EP16.05.2002
ClassificationIPC:C07K16/24, C12N15/13, C12N15/63, C12P21/08, A61K39/395
[2003/15]
CPC:
C07K16/24 (EP,KR,US); A61P1/00 (EP); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P17/00 (EP);
A61P19/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P9/10 (EP);
A61K2039/505 (EP,US); C07K2317/21 (EP,US); C07K2317/33 (EP,US);
C07K2317/34 (EP,US); C07K2317/565 (EP,US); C07K2317/76 (EP,US);
C07K2317/92 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/15]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RO30.01.2003
SI30.01.2003
TitleGerman:ANTIKÖRPER GEGEN MENSCHLICHES MCP-1[2008/47]
English:ANTIBODIES TO HUMAN MCP-1[2003/15]
French:ANTICORPS ANTI-MCP-1 HUMAIN[2008/47]
Former [2003/15]ANTIKÖRPER GEGEN MENSCHLISCHES MCP-1
Former [2003/15]ANTICORPS A MCP-1 HUMAIN
Entry into regional phase30.01.2003National basic fee paid 
30.01.2003Designation fee(s) paid 
30.01.2003Examination fee paid 
Examination procedure12.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.01.2003Examination requested  [2003/15]
25.10.2007Despatch of a communication from the examining division (Time limit: M04)
08.04.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
29.05.2008Reply to a communication from the examining division
28.10.2008Communication of intention to grant the patent
09.02.2009Fee for grant paid
09.02.2009Fee for publishing/printing paid
Opposition(s)29.12.2009No opposition filed within time limit [2010/09]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
29.05.2008Request for further processing filed
29.05.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
30.06.2003Renewal fee patent year 03
30.06.2004Renewal fee patent year 04
30.06.2005Renewal fee patent year 05
30.06.2006Renewal fee patent year 06
02.07.2007Renewal fee patent year 07
28.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY25.03.2009
DK25.03.2009
FI25.03.2009
SE25.06.2009
IE29.06.2009
LU29.06.2009
MC30.06.2009
[2011/45]
Former [2011/21]DK25.03.2009
FI25.03.2009
SE25.06.2009
IE29.06.2009
LU29.06.2009
MC30.06.2009
Former [2010/21]DK25.03.2009
FI25.03.2009
SE25.06.2009
IE29.06.2009
MC30.06.2009
Former [2010/08]DK25.03.2009
FI25.03.2009
SE25.06.2009
MC30.06.2009
Former [2010/07]FI25.03.2009
SE25.06.2009
MC30.06.2009
Former [2009/37]FI25.03.2009
SE25.06.2009
Cited inInternational search[Y]US5985279  (WALDMANN HERMAN [GB], et al) [Y] 8 * claim 15 *;
 [XY]  - BADIE BEHNAM ET AL, "In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.", NEUROSURGERY (BALTIMORE), (199905), vol. 44, no. 5, ISSN 0148-396X, pages 1077 - 1083, XP000984052 [X] 1-4 * the whole document * [Y] 8

DOI:   http://dx.doi.org/10.1097/00006123-199905000-00075
 [A]  - BADOLATO RAFFAELE ET AL, "Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes.", BLOOD, (1997), vol. 90, no. 7, ISSN 0006-4971, pages 2804 - 2809, XP002188285 [A] 1-13 * the whole document *
Examination   - Little, M. et al (2000) Immunology Today 21:364-370
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.